COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur (Curie-O-SA)
Volunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection

About this trial
This is an interventional health services research trial for Volunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection focused on measuring Adults, Volunteers
Eligibility Criteria
Inclusion Criteria:
- Person, adult volunteer outside of any acute infectious episode with SARS-CoV-2* (see paragraph indication), working at the Institute Curie and able to exercise their professional activity on one of the 3 sites of the Institute Curie: Paris, Orsay or Saint Cloud, or on the Campus of the Institute Pasteur.
- Person aged 18 or over.
- Information and consent of the person to the procedures related to the study (cf. information note / consent).
From November 2020, person having presented at least one of the following criteria since January 2020:
- A positive diagnostic test for SARS-COV-2 by PCR on a nasopharyngeal sample or antigenic test,
- A positive SARS-CoV-2 serology,
- An anosmia or / and an ageusia,
- A respiratory infection ** associated with digestive signs **
whatever the working methods during confinement * Subjects who are not showing active SARS-CoV-2 infection are considered volunteers at the time of inclusion: people with no clinical signs ** suggestive of SARS-CoV-2 infection at the time of collection or having had an end of symptoms for more than 7 days [1].
** fever, fatigue, cough, shortness of breath, difficulty to breath, loss of taste or smell, headache, body aches, conjunctivitis or cold, digestive problems (vomiting, diarrhea), whether or not the signs led to sick leave, treatment and / or hospitalization [2].
Exclusion Criteria:
- Declaration by the subject of signs suggestive of Coronavirus Infectious Disease 2019 (COVID-19) infection with SARS-CoV-2 in progress or for which the end of symptoms dates from less than 7 days
- Inability to submit to study monitoring for geographic, social or psychological reasons
Sites / Locations
- Institut Curie
- Institut Pasteur
Arms of the Study
Arm 1
Other
Subjects who are not showing active SARS-Cov2 infection